CLINICAL TRIALS PROFILE FOR PERFLUOROHEXYLOCTANE
✉ Email this page to a colleague
All Clinical Trials for PERFLUOROHEXYLOCTANE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00403702 ↗ | Comparison High-Density Silicone Oils in Retinal Detachment | Unknown status | Asociación para Evitar la Ceguera en México | Phase 2/Phase 3 | 2006-08-01 | The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments. |
| NCT03333057 ↗ | Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) | Completed | Novaliq GmbH | Phase 2 | 2018-01-03 | This study will evaluate the efficacy, safety and tolerability of perfluorohexyloctane (NOV03) at two different dosing regimens compared to saline solution in subjects with Dry Eye Disease (DED). |
| NCT04139798 ↗ | Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) | Completed | Bausch & Lomb Incorporated | Phase 3 | 2020-07-20 | This trial will evaluate the efficacy, safety, and tolerability of NOV03 ophthalmic solution in comparison to a saline control for the treatment of the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). |
| NCT04139798 ↗ | Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) | Completed | Novaliq GmbH | Phase 3 | 2020-07-20 | This trial will evaluate the efficacy, safety, and tolerability of NOV03 ophthalmic solution in comparison to a saline control for the treatment of the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). |
| NCT04140227 ↗ | Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) | Recruiting | Bausch & Lomb Incorporated | Phase 3 | 2020-09-24 | The objectives of this trial are to evaluate the safety and tolerability of perfluorohexyloctane (NOV03) ophthalmic solution during long-term use in subjects with Dry Eye Disease (DED) associated with MGD (Meibomian Gland Dysfunction). Further objective is to evaluate the efficacy of perfluorohexyloctane (NOV03) solution during long-term use in subjects with DED associated with MGD. |
| NCT04140227 ↗ | Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) | Recruiting | Novaliq GmbH | Phase 3 | 2020-09-24 | The objectives of this trial are to evaluate the safety and tolerability of perfluorohexyloctane (NOV03) ophthalmic solution during long-term use in subjects with Dry Eye Disease (DED) associated with MGD (Meibomian Gland Dysfunction). Further objective is to evaluate the efficacy of perfluorohexyloctane (NOV03) solution during long-term use in subjects with DED associated with MGD. |
| NCT06176651 ↗ | Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers | Completed | Gordon Schanzlin New Vision | Phase 4 | 2023-09-21 | Miebo (Perfluorohexyloctane) is a novel, non-aqueous, single entity, preservative free, ophthalmic drop. This drop was recently approved by the Food and Drug Administration (FDA) for the treatment of Meibomian Gland Disease (MGD). All published data on Miebo has been done in non-contact lens wearers. As contact lens dropout rates seem to be an ongoing problem for practitioners, we are performing this study utilizing this novel new drug with contact lens patients to determine if the drops assist comfort in typical soft contact lens wearing patients. If the study determines that Miebo assists in the overall comfort of contact lens patients this could be a possible way to help keep patients in their contact lenses longer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PERFLUOROHEXYLOCTANE
Condition Name
Clinical Trial Locations for PERFLUOROHEXYLOCTANE
Trials by Country
Clinical Trial Progress for PERFLUOROHEXYLOCTANE
Clinical Trial Phase
Clinical Trial Sponsors for PERFLUOROHEXYLOCTANE
Sponsor Name
